Literature DB >> 6320495

A multisample apparatus for kinetic evaluation of skin penetration in vitro: the influence of viability and metabolic status of the skin.

J M Holland, J Y Kao, M J Whitaker.   

Abstract

An apparatus is described for convenient in vitro quantitation of the rate, extent, and character of living skin penetration by chemicals. Evidence that viability markedly affects epidermal penetration was based upon observations utilizing benzo(a)pyrene. This compound displayed saturation kinetics in the extent of penetration, marked elevation in the rate, and extent of penetration following induction of epidermal mixed function oxidase and negligible penetration of skin previously frozen. These data are interpreted to indicate that for certain compounds, such as benzo(a)pyrene where cutaneous metabolism is expected, meaningful in vitro measures of skin penetration should take into consideration the biochemical viability and metabolic status of the tissue.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6320495     DOI: 10.1016/0041-008x(84)90312-0

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

1.  Skin structure and metabolism: relevance to the design of cutaneous therapeutics.

Authors:  D A Bucks
Journal:  Pharm Res       Date:  1984-07       Impact factor: 4.200

2.  Transdermal drug transport and metabolism. I. Comparison of in vitro and in vivo results.

Authors:  D B Guzek; A H Kennedy; S C McNeill; E Wakshull; R O Potts
Journal:  Pharm Res       Date:  1989-01       Impact factor: 4.200

3.  Transdermal drug transport and metabolism. II. The role of competing kinetic events.

Authors:  R O Potts; S C McNeill; C R Desbonnet; E Wakshull
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

4.  Prediction of the percutaneous penetration and metabolism of dodecyl decaethoxylate in rats using in vitro models.

Authors:  C S Roper; D Howes; P G Blain; F M Williams
Journal:  Arch Toxicol       Date:  1995       Impact factor: 5.153

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.